Navigation Links
US Oncology Applauds Senator Daschle's Appointment as Director of President-Elect Obama's New White House Office of Health Reform
Date:12/12/2008

Daschle's Extensive Health Care Policy and Legislative Background Assures Strong Leadership for Office's Mission to Drive Widespread Health Care Reform

WASHINGTON, Dec. 12 /PRNewswire-USNewswire/ --US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, today praised President-elect Barack Obama's selection of former Senator Tom Daschle to lead his newly established White House Office of Health Reform, which will focus on advancing top health care policy reform initiatives, including those to expand coverage and temper rising health care costs.

"US Oncology applauds the appointment of Sen. Daschle to drive the development of practical policy solutions designed to address our nation's most pressing health care challenges, such as the provision of affordable and accessible health care for all," said Roy Beveridge, M.D., Chairman of the US Oncology Public Policy Steering Committee. "We look forward to collaborating with Sen. Daschle and his colleagues in the Obama administration to craft lasting solutions for these issues, notably, to ensure that all Americans living with cancer are able to secure unrestricted access to vital health care services."

Jeanne Lambrew, a former aide to President Bill Clinton, senior fellow at the Center for American Progress and associate professor of public affairs at the Lyndon B. Johnson School of Public Affairs at the University of Texas, will serve as deputy director of the new office. Ms. Lambrew specializes in health policy research on the uninsured, Medicaid, Medicare and long term care.

"President-elect Obama's selection of Sen. Daschle and Ms. Lambrew to be the head architects of his health reform plan reflects his administration's commitment to prioritizing key health care advancements, including expanding access to care, promoting health information technology and focusing on preventive care, among others," said Dr. Beveridge. "Through linking US Oncology's extensive iKnowMed oncology-specific electronic medical records system to our clinical, evidence-based cancer care treatment pathways, we have demonstrated our commitment to utilizing health information technology and quality measures in order to bring the highest quality cancer care directly to the patient's community. We hope to work with Sen. Daschle and his colleagues to apply comparable strategies to achieve similar positive effects across the spectrum of health care delivery in 2009."

About US Oncology, Inc.

Headquartered in Houston, US Oncology works closely with physicians, manufacturers and payers to enhance patient access to advanced cancer care in the community setting. US Oncology supports the nation's foremost cancer treatment and research network in its efforts to accelerate the availability and use of scientific, evidence-based medicine.

According to the company's last quarterly earnings report, US Oncology is affiliated with more than 1,200 physicians operating in approximately 485 locations, including 92 cancer centers and radiation facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.


'/>"/>
SOURCE US Oncology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Unveils MR Oncology Applications and Dedicated Breast Scanner at RSNA 2008
2. TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries
3. Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile
4. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
5. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
6. US Oncology Applauds Senator Baucuss Healthcare Reform Call to Action for 2009, Supports Collaborative Measures to Enhance Cancer Patients Access to Care While Improving Quality and Access
7. New Orthopedic Oncology Fellowship Program at Mount Clemens Brings Highly Trained Surgeons to State
8. Partial Breast Irradiation Now Provided by Rocky Mountain Oncology Center
9. US Oncology Reports Third Quarter 2008 Results
10. OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance
11. Premier Radiation Oncology Meeting Breaks Attendance, Exhibit Space Record at Boston Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... January 16, 2017 , ... With the Grand Opening Event planned for February ... by sports teams and the general public. Built in five months by Centerpoint, the ... converted into basketball or pickleball courts. The space is also suitable for indoor soccer ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s fastest ... Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, MD, ... Care, a division of SightMD. Dr. Giamos will practice primarily out of SightMD’s ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... their recent partnership with an innovator in the wheelchair accessibility industry, BraunAbility ... their dealer salespeople to sell wheelchair accessible vehicles. With this new incentive plan, ...
(Date:1/16/2017)... Hills, CA (PRWEB) , ... January 16, 2017 ... ... a manuscript in the Aesthetic Surgery Journal , the official journal of ... he conducted on lower eyelid retraction surgery. The procedure is designed to correct ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... YORK , Jan. 17, 2017 Immune ... stage biopharmaceutical company, announced today that it will hold ... Symposium on Acute Leukemias (ISAL) XVI in ... is entitled:  "Reinforcing the Efficacy of Immunotherapy for the ... take place on Monday February 20 th , 2017 from ...
(Date:1/17/2017)... Jan. 17, 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... molecular diagnostic tests and pathology services for evaluating risks ... letter dated January 13, 2017 from the NASDAQ Listing ... with the requirement of the NASDAQ Stock Market to ... share. The letter noted that for the ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of the ... offering. ... comprehensive report, identifies and profiles the leading 200 manufacturers and distributors of ... the United States and Europe ... . Profile information for each company in The Top ...
Breaking Medicine Technology: